Evidence map›Paper›PMID 28607633›Full record

ArticleOxidative medicine and cellular longevity2017

Pterostilbene 4'-

Yingqing Chen, Jeongmin Park, Yeonsoo Joe, Hyeok-Jun Park, Seung-Joo Jekal, Daisuke Sato, Hiroki Hamada, Hun Taeg Chung

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Pterostilbene 4'-Oxidative medicine and cellular longevity · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yingqing ChenDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea.
Jeongmin ParkDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea.
Yeonsoo JoeDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea.
Hyeok-Jun ParkDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea.
Seung-Joo JekalDepartment of Clinical Laboratory Science, Wonkwang Health Science University, Iksan 570-750, Republic of Korea.
Daisuke SatoDepartment of Life Science, Okayama University, Okayama 770-0005, Japan.
Hiroki HamadaDepartment of Life Science, Okayama University, Okayama 770-0005, Japan.
Hun Taeg ChungDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea.ORCID 0000-0003-4802-7467
University of Ulsan · KROkayama University · JPWonKwang Health Science University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pterostilbene, a dimethyl ester analog of resveratrol, has anti-inflammatory and antioxidative effects and alters cell proliferation. Tristetraprolin (TTP) promotes the degradation of proinflammatory mediators via binding to adenosine and uridine- (AU-) rich elements (ARE) located in the 3'-untranslated regions of mRNAs. Here, we utilized pterostilbene 4'-

Indexed as

AnimalsColitisDisease Models, AnimalGlucosidesMaleMiceMice, KnockoutStilbenesTristetraprolinGlucosidespterostilbeneStilbenesTristetraprolin

Identifiers

PMID28607633
PMCPMC5451844
OpenAlexW2615561205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.